linkedin post 2013-11-20 06:36:16

THE PHARMA PATENT CLIFF. By 2016, the pharma industry will have total patent losses of ~$150 billion.” Brand pharma has exclusivity from IP and commands top pricing. When the patents expire, there is intense competition from generics to take market share. First-to-file generics get 180 day market exclusivity, at a lower price. When the exclusivity protection ends, other generics can enter the market and price erodes further. These are the dynamics of a pharma product life-cycle.”
”

http://lnkd.in/dRzKvfa

View in LinkedIn